Viewing Study NCT04521803


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2025-12-30 @ 4:31 PM
Study NCT ID: NCT04521803
Status: RECRUITING
Last Update Posted: 2025-08-21
First Post: 2020-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Sponsor: University of Cape Town
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module